Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for ID4_TCF4_SNAI2
Z-value: 0.14
Motif logo
Transcription factors associated with ID4_TCF4_SNAI2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ID4
|
ENSG00000172201.6 | inhibitor of DNA binding 4, HLH protein |
|
TCF4
|
ENSG00000196628.9 | transcription factor 4 |
|
SNAI2
|
ENSG00000019549.4 | snail family transcriptional repressor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TCF4 | hg19_v2_chr18_-_53253112_53253199 | -0.56 | 7.9e-04 | Click! |
| SNAI2 | hg19_v2_chr8_-_49833978_49833996 | -0.07 | 6.9e-01 | Click! |
| ID4 | hg19_v2_chr6_+_19837592_19837621 | 0.01 | 9.5e-01 | Click! |
Activity profile of ID4_TCF4_SNAI2 motif
Sorted Z-values of ID4_TCF4_SNAI2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr8_+_120220561 | 13.89 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chr1_+_60280458 | 13.52 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr19_+_7660716 | 9.35 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr11_+_27062860 | 7.42 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr18_+_47088401 | 7.41 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr11_+_27062272 | 7.12 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr11_+_27062502 | 6.94 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr17_-_46035187 | 6.44 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
| chr16_+_68771128 | 6.15 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
| chr4_-_77819002 | 6.15 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr15_+_85427903 | 6.12 |
ENST00000286749.3
ENST00000394573.1 ENST00000537703.1 |
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1 |
| chr17_-_7165662 | 6.11 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr17_+_9548845 | 6.02 |
ENST00000570475.1
ENST00000285199.7 |
USP43
|
ubiquitin specific peptidase 43 |
| chrX_+_70443050 | 5.98 |
ENST00000361726.6
|
GJB1
|
gap junction protein, beta 1, 32kDa |
| chr10_-_82049424 | 5.88 |
ENST00000372213.3
|
MAT1A
|
methionine adenosyltransferase I, alpha |
| chr1_-_27240455 | 5.77 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
| chr5_+_89854595 | 5.74 |
ENST00000405460.2
|
GPR98
|
G protein-coupled receptor 98 |
| chrX_+_105969893 | 5.68 |
ENST00000255499.2
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr16_+_23194033 | 5.67 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
| chr15_+_85427879 | 5.64 |
ENST00000338602.2
ENST00000537216.1 ENST00000538177.1 ENST00000537624.1 |
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1 |
| chr11_+_45944190 | 5.56 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr19_+_6464502 | 5.52 |
ENST00000308243.7
|
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr19_+_6464243 | 5.52 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr7_-_73184588 | 5.25 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr9_+_17579084 | 5.15 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chr22_-_18923655 | 5.08 |
ENST00000438924.1
ENST00000457083.1 ENST00000420436.1 ENST00000334029.2 ENST00000357068.6 |
PRODH
|
proline dehydrogenase (oxidase) 1 |
| chr5_+_156693091 | 4.99 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr1_-_57285038 | 4.93 |
ENST00000343433.6
|
C1orf168
|
chromosome 1 open reading frame 168 |
| chr5_+_156693159 | 4.92 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr2_+_47596287 | 4.87 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr7_+_142982023 | 4.83 |
ENST00000359333.3
ENST00000409244.1 ENST00000409541.1 ENST00000410004.1 |
TMEM139
|
transmembrane protein 139 |
| chr19_+_38755237 | 4.80 |
ENST00000587516.1
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr2_-_165477971 | 4.80 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr14_+_67999999 | 4.75 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
| chr11_-_117698787 | 4.72 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr12_-_6484715 | 4.71 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr9_+_139847347 | 4.60 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
| chr19_+_38755042 | 4.57 |
ENST00000301244.7
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr16_-_66952779 | 4.45 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
| chr7_-_139168434 | 4.42 |
ENST00000340940.4
|
KLRG2
|
killer cell lectin-like receptor subfamily G, member 2 |
| chr1_+_16375284 | 4.38 |
ENST00000375667.3
|
CLCNKB
|
chloride channel, voltage-sensitive Kb |
| chr8_-_144815966 | 4.34 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
| chr2_-_224702201 | 4.26 |
ENST00000446015.2
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit |
| chr4_-_76555657 | 4.22 |
ENST00000307465.4
|
CDKL2
|
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
| chr3_-_182833863 | 4.18 |
ENST00000492597.1
|
MCCC1
|
methylcrotonoyl-CoA carboxylase 1 (alpha) |
| chr2_+_73144604 | 4.18 |
ENST00000258106.6
|
EMX1
|
empty spiracles homeobox 1 |
| chr12_-_101604185 | 4.15 |
ENST00000536262.2
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8 |
| chr15_+_50474385 | 4.12 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr19_-_7939319 | 4.12 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
| chr18_+_47087390 | 4.02 |
ENST00000583083.1
|
LIPG
|
lipase, endothelial |
| chr11_-_26593649 | 3.99 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
| chr21_-_42879909 | 3.99 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
| chr7_+_107301447 | 3.98 |
ENST00000440056.1
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4 |
| chr10_-_21463116 | 3.97 |
ENST00000417816.2
|
NEBL
|
nebulette |
| chr1_-_151804222 | 3.90 |
ENST00000392697.3
|
RORC
|
RAR-related orphan receptor C |
| chr17_+_52978185 | 3.86 |
ENST00000572405.1
ENST00000572158.1 ENST00000540336.1 ENST00000572298.1 ENST00000536554.1 ENST00000575333.1 ENST00000570499.1 ENST00000572576.1 |
TOM1L1
|
target of myb1 (chicken)-like 1 |
| chr16_-_20367584 | 3.86 |
ENST00000570689.1
|
UMOD
|
uromodulin |
| chr19_+_38755203 | 3.86 |
ENST00000587090.1
ENST00000454580.3 |
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr11_-_117698765 | 3.83 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr9_-_97401782 | 3.82 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr19_-_10697895 | 3.82 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr2_+_228029281 | 3.75 |
ENST00000396578.3
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen) |
| chr21_-_42880075 | 3.74 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
| chr12_-_371994 | 3.69 |
ENST00000343164.4
ENST00000436453.1 ENST00000445055.2 ENST00000546319.1 |
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13 |
| chr2_+_103236004 | 3.69 |
ENST00000233969.2
|
SLC9A2
|
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
| chr1_-_151804314 | 3.63 |
ENST00000318247.6
|
RORC
|
RAR-related orphan receptor C |
| chr15_+_50474412 | 3.62 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr11_-_26593779 | 3.59 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
| chr22_-_21581926 | 3.56 |
ENST00000401924.1
|
GGT2
|
gamma-glutamyltransferase 2 |
| chr17_+_73521763 | 3.56 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
| chr1_-_201391149 | 3.55 |
ENST00000555948.1
ENST00000556362.1 |
TNNI1
|
troponin I type 1 (skeletal, slow) |
| chr17_+_37894179 | 3.54 |
ENST00000577695.1
ENST00000309156.4 ENST00000309185.3 |
GRB7
|
growth factor receptor-bound protein 7 |
| chr5_-_54281407 | 3.53 |
ENST00000381403.4
|
ESM1
|
endothelial cell-specific molecule 1 |
| chr1_+_1981890 | 3.52 |
ENST00000378567.3
ENST00000468310.1 |
PRKCZ
|
protein kinase C, zeta |
| chr10_+_99332529 | 3.50 |
ENST00000455090.1
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr5_-_147211226 | 3.49 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr2_-_238499337 | 3.46 |
ENST00000411462.1
ENST00000409822.1 |
RAB17
|
RAB17, member RAS oncogene family |
| chr10_+_99332198 | 3.43 |
ENST00000307518.5
ENST00000298808.5 ENST00000370655.1 |
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr16_+_67465016 | 3.43 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr7_-_137531606 | 3.43 |
ENST00000288490.5
|
DGKI
|
diacylglycerol kinase, iota |
| chr5_+_169532896 | 3.41 |
ENST00000306268.6
ENST00000449804.2 |
FOXI1
|
forkhead box I1 |
| chr12_-_103310987 | 3.40 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
| chr1_+_2005425 | 3.40 |
ENST00000461106.2
|
PRKCZ
|
protein kinase C, zeta |
| chr14_-_67878917 | 3.39 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
| chr14_-_80677815 | 3.38 |
ENST00000557125.1
ENST00000555750.1 |
DIO2
|
deiodinase, iodothyronine, type II |
| chr12_-_118406777 | 3.37 |
ENST00000339824.5
|
KSR2
|
kinase suppressor of ras 2 |
| chr8_+_32405728 | 3.37 |
ENST00000523079.1
ENST00000338921.4 ENST00000356819.4 ENST00000287845.5 ENST00000341377.5 |
NRG1
|
neuregulin 1 |
| chr7_-_139168402 | 3.35 |
ENST00000393039.2
|
KLRG2
|
killer cell lectin-like receptor subfamily G, member 2 |
| chr6_+_150464155 | 3.34 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr11_-_26593677 | 3.27 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
| chr2_+_120770686 | 3.27 |
ENST00000331393.4
ENST00000443124.1 |
EPB41L5
|
erythrocyte membrane protein band 4.1 like 5 |
| chr2_-_224702270 | 3.26 |
ENST00000396654.2
ENST00000396653.2 ENST00000423110.1 ENST00000443700.1 |
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit |
| chrX_+_46940254 | 3.24 |
ENST00000336169.3
|
RGN
|
regucalcin |
| chr1_-_209979465 | 3.20 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
| chr8_+_134125727 | 3.20 |
ENST00000521107.1
|
TG
|
thyroglobulin |
| chr11_-_34535332 | 3.19 |
ENST00000257832.2
ENST00000429939.2 |
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
| chr12_+_56473628 | 3.19 |
ENST00000549282.1
ENST00000549061.1 ENST00000267101.3 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
| chr2_-_241835561 | 3.16 |
ENST00000388934.4
|
C2orf54
|
chromosome 2 open reading frame 54 |
| chr4_+_106473768 | 3.16 |
ENST00000265154.2
ENST00000420470.2 |
ARHGEF38
|
Rho guanine nucleotide exchange factor (GEF) 38 |
| chr18_-_47721447 | 3.14 |
ENST00000285039.7
|
MYO5B
|
myosin VB |
| chr22_+_45680822 | 3.14 |
ENST00000216211.4
ENST00000396082.2 |
UPK3A
|
uroplakin 3A |
| chr2_-_238499725 | 3.12 |
ENST00000264601.3
|
RAB17
|
RAB17, member RAS oncogene family |
| chr10_+_45406627 | 3.12 |
ENST00000389583.4
|
TMEM72
|
transmembrane protein 72 |
| chr6_-_47010061 | 3.10 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
| chr2_-_238499303 | 3.09 |
ENST00000409576.1
|
RAB17
|
RAB17, member RAS oncogene family |
| chr16_+_67034466 | 3.08 |
ENST00000535696.1
|
CES4A
|
carboxylesterase 4A |
| chr8_+_102504651 | 3.06 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr7_+_107301065 | 3.06 |
ENST00000265715.3
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4 |
| chr4_-_40632605 | 3.05 |
ENST00000514014.1
|
RBM47
|
RNA binding motif protein 47 |
| chr2_+_234621551 | 3.04 |
ENST00000608381.1
ENST00000373414.3 |
UGT1A1
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A8 UDP glucuronosyltransferase 1 family, polypeptide A5 |
| chr17_-_7166500 | 3.04 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
| chr5_+_78407602 | 3.03 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
| chr16_-_745946 | 3.01 |
ENST00000562563.1
|
FBXL16
|
F-box and leucine-rich repeat protein 16 |
| chr2_-_224702257 | 2.98 |
ENST00000409375.1
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit |
| chr17_-_36105009 | 2.95 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
| chr16_+_67034456 | 2.95 |
ENST00000540579.1
|
CES4A
|
carboxylesterase 4A |
| chr5_-_169626104 | 2.93 |
ENST00000520275.1
ENST00000506431.2 |
CTB-27N1.1
|
CTB-27N1.1 |
| chr4_-_155533787 | 2.92 |
ENST00000407946.1
ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG
|
fibrinogen gamma chain |
| chr7_+_140774032 | 2.92 |
ENST00000565468.1
|
TMEM178B
|
transmembrane protein 178B |
| chr1_+_18807424 | 2.91 |
ENST00000400664.1
|
KLHDC7A
|
kelch domain containing 7A |
| chr14_-_80677613 | 2.91 |
ENST00000556811.1
|
DIO2
|
deiodinase, iodothyronine, type II |
| chr19_+_35532612 | 2.90 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr10_+_124030819 | 2.89 |
ENST00000260723.4
ENST00000368994.2 |
BTBD16
|
BTB (POZ) domain containing 16 |
| chr20_+_43029911 | 2.88 |
ENST00000443598.2
ENST00000316099.4 ENST00000415691.2 |
HNF4A
|
hepatocyte nuclear factor 4, alpha |
| chr2_+_47596634 | 2.87 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
| chr11_+_7273181 | 2.86 |
ENST00000318881.6
|
SYT9
|
synaptotagmin IX |
| chr1_-_201346761 | 2.86 |
ENST00000455702.1
ENST00000422165.1 ENST00000367318.5 ENST00000367320.2 ENST00000438742.1 ENST00000412633.1 ENST00000458432.2 ENST00000421663.2 ENST00000367322.1 ENST00000509001.1 |
TNNT2
|
troponin T type 2 (cardiac) |
| chr6_-_41006928 | 2.85 |
ENST00000244565.3
|
UNC5CL
|
unc-5 homolog C (C. elegans)-like |
| chr3_-_120400960 | 2.85 |
ENST00000476082.2
|
HGD
|
homogentisate 1,2-dioxygenase |
| chr2_+_108905325 | 2.82 |
ENST00000438339.1
ENST00000409880.1 ENST00000437390.2 |
SULT1C2
|
sulfotransferase family, cytosolic, 1C, member 2 |
| chr19_+_3933085 | 2.82 |
ENST00000168977.2
ENST00000599576.1 |
NMRK2
|
nicotinamide riboside kinase 2 |
| chr4_-_21950356 | 2.82 |
ENST00000447367.2
ENST00000382152.2 |
KCNIP4
|
Kv channel interacting protein 4 |
| chr2_-_238499131 | 2.79 |
ENST00000538644.1
|
RAB17
|
RAB17, member RAS oncogene family |
| chr21_+_38071430 | 2.79 |
ENST00000290399.6
|
SIM2
|
single-minded family bHLH transcription factor 2 |
| chr18_-_47376197 | 2.79 |
ENST00000592688.1
|
MYO5B
|
myosin VB |
| chr19_+_3933579 | 2.78 |
ENST00000593949.1
|
NMRK2
|
nicotinamide riboside kinase 2 |
| chr19_-_54676884 | 2.77 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
| chr3_-_46904946 | 2.77 |
ENST00000292327.4
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
| chr21_+_39628780 | 2.76 |
ENST00000417042.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr3_-_121740969 | 2.76 |
ENST00000393631.1
ENST00000273691.3 ENST00000344209.5 |
ILDR1
|
immunoglobulin-like domain containing receptor 1 |
| chr2_+_171673072 | 2.76 |
ENST00000358196.3
ENST00000375272.1 |
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa) |
| chr2_+_223289208 | 2.75 |
ENST00000321276.7
|
SGPP2
|
sphingosine-1-phosphate phosphatase 2 |
| chr17_+_7517264 | 2.75 |
ENST00000593717.1
ENST00000572182.1 ENST00000574539.1 ENST00000576728.1 ENST00000575314.1 ENST00000570547.1 ENST00000572262.1 ENST00000576478.1 |
AC007421.1
SHBG
|
AC007421.1 sex hormone-binding globulin |
| chr22_-_21580582 | 2.75 |
ENST00000424627.1
|
GGT2
|
gamma-glutamyltransferase 2 |
| chr19_-_54676846 | 2.74 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
| chr10_+_45406764 | 2.74 |
ENST00000544540.1
|
TMEM72
|
transmembrane protein 72 |
| chr2_+_155555201 | 2.70 |
ENST00000544049.1
|
KCNJ3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
| chr9_+_80912059 | 2.70 |
ENST00000347159.2
ENST00000376588.3 |
PSAT1
|
phosphoserine aminotransferase 1 |
| chr5_-_54281491 | 2.69 |
ENST00000381405.4
|
ESM1
|
endothelial cell-specific molecule 1 |
| chr15_+_69857515 | 2.69 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
| chr1_+_47603109 | 2.68 |
ENST00000371890.3
ENST00000294337.3 ENST00000371891.3 |
CYP4A22
|
cytochrome P450, family 4, subfamily A, polypeptide 22 |
| chr21_+_39628852 | 2.68 |
ENST00000398938.2
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr2_-_241080069 | 2.67 |
ENST00000319460.1
|
OTOS
|
otospiralin |
| chr17_+_52978156 | 2.65 |
ENST00000348161.4
|
TOM1L1
|
target of myb1 (chicken)-like 1 |
| chr12_-_113573495 | 2.65 |
ENST00000446861.3
|
RASAL1
|
RAS protein activator like 1 (GAP1 like) |
| chr14_+_95078714 | 2.64 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| chr2_-_228028829 | 2.64 |
ENST00000396625.3
ENST00000329662.7 |
COL4A4
|
collagen, type IV, alpha 4 |
| chr4_+_152330390 | 2.63 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr1_+_24646263 | 2.63 |
ENST00000524724.1
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr2_-_230579185 | 2.63 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr19_-_5838734 | 2.61 |
ENST00000532464.1
ENST00000528505.1 |
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase) |
| chr1_+_54359854 | 2.60 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
| chr16_-_74808710 | 2.60 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
| chr4_-_40516560 | 2.60 |
ENST00000513473.1
|
RBM47
|
RNA binding motif protein 47 |
| chr7_-_44365020 | 2.60 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr11_-_45307817 | 2.60 |
ENST00000020926.3
|
SYT13
|
synaptotagmin XIII |
| chr8_-_28347737 | 2.59 |
ENST00000517673.1
ENST00000518734.1 ENST00000346498.2 ENST00000380254.2 |
FBXO16
|
F-box protein 16 |
| chr21_+_41239243 | 2.58 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
| chr2_+_108905095 | 2.58 |
ENST00000251481.6
ENST00000326853.5 |
SULT1C2
|
sulfotransferase family, cytosolic, 1C, member 2 |
| chr17_+_52978107 | 2.58 |
ENST00000445275.2
|
TOM1L1
|
target of myb1 (chicken)-like 1 |
| chr19_-_51471381 | 2.57 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_-_153538292 | 2.57 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
| chr3_-_46904918 | 2.57 |
ENST00000395869.1
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
| chr5_+_76114758 | 2.56 |
ENST00000514165.1
ENST00000296677.4 |
F2RL1
|
coagulation factor II (thrombin) receptor-like 1 |
| chr9_-_116840728 | 2.56 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr4_-_16085340 | 2.55 |
ENST00000508167.1
|
PROM1
|
prominin 1 |
| chr1_-_120311517 | 2.54 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
| chr4_+_1003742 | 2.54 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
| chr13_+_76334498 | 2.53 |
ENST00000534657.1
|
LMO7
|
LIM domain 7 |
| chr12_-_322504 | 2.52 |
ENST00000424061.2
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
| chr11_+_71903169 | 2.51 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
| chr13_+_76334795 | 2.49 |
ENST00000526202.1
ENST00000465261.2 |
LMO7
|
LIM domain 7 |
| chr11_+_19799327 | 2.48 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
| chr16_-_68269971 | 2.47 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr4_-_16085314 | 2.47 |
ENST00000510224.1
|
PROM1
|
prominin 1 |
| chr12_+_109273806 | 2.47 |
ENST00000228476.3
ENST00000547768.1 |
DAO
|
D-amino-acid oxidase |
| chr13_+_76334567 | 2.46 |
ENST00000321797.8
|
LMO7
|
LIM domain 7 |
| chr11_-_62783276 | 2.46 |
ENST00000535878.1
ENST00000545207.1 |
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8 |
| chr16_-_3086927 | 2.45 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
| chr8_-_81083731 | 2.44 |
ENST00000379096.5
|
TPD52
|
tumor protein D52 |
| chr17_-_8702667 | 2.44 |
ENST00000329805.4
|
MFSD6L
|
major facilitator superfamily domain containing 6-like |
| chr20_+_49348109 | 2.43 |
ENST00000396039.1
|
PARD6B
|
par-6 family cell polarity regulator beta |
| chr19_-_3480540 | 2.43 |
ENST00000215531.4
|
C19orf77
|
chromosome 19 open reading frame 77 |
| chrX_-_102565932 | 2.42 |
ENST00000372674.1
ENST00000372677.3 |
BEX2
|
brain expressed X-linked 2 |
| chr3_-_190580404 | 2.42 |
ENST00000442080.1
|
GMNC
|
geminin coiled-coil domain containing |
| chr1_-_230561475 | 2.42 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
| chr8_-_134114887 | 2.41 |
ENST00000519341.1
|
SLA
|
Src-like-adaptor |
| chr16_-_20362147 | 2.41 |
ENST00000396142.2
|
UMOD
|
uromodulin |
| chr5_+_68788594 | 2.41 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr16_-_66952742 | 2.40 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
Network of associatons between targets according to the STRING database.
First level regulatory network of ID4_TCF4_SNAI2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 11.5 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 2.6 | 13.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 2.6 | 18.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.8 | 10.7 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.8 | 23.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.6 | 6.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.5 | 7.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.5 | 7.6 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 1.5 | 6.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.5 | 3.0 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 1.5 | 4.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 1.4 | 2.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.3 | 5.4 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 1.3 | 6.7 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.3 | 10.7 | GO:0006562 | proline catabolic process(GO:0006562) |
| 1.3 | 9.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.3 | 6.5 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 1.3 | 6.3 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.2 | 4.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.1 | 4.5 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 1.1 | 7.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.1 | 16.3 | GO:0015705 | iodide transport(GO:0015705) |
| 1.1 | 5.4 | GO:1904640 | response to methionine(GO:1904640) |
| 1.1 | 14.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 1.1 | 1.1 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.1 | 3.2 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 1.1 | 3.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.1 | 5.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.0 | 7.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 1.0 | 3.0 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 1.0 | 2.9 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
| 1.0 | 2.9 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 1.0 | 2.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 1.0 | 13.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.0 | 9.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.9 | 3.6 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.9 | 3.5 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.9 | 8.6 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.9 | 15.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.9 | 2.6 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.8 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.8 | 2.5 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.8 | 3.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.8 | 2.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.8 | 4.7 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.8 | 3.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.8 | 6.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.8 | 28.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.8 | 6.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.8 | 3.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.8 | 16.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.8 | 6.1 | GO:0032439 | endosome localization(GO:0032439) |
| 0.8 | 2.3 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.8 | 3.8 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.8 | 1.5 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.8 | 9.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.8 | 7.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.8 | 5.3 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.7 | 3.7 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.7 | 19.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.7 | 3.7 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.7 | 17.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.7 | 5.0 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.7 | 2.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 | 4.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.7 | 9.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.7 | 2.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.7 | 0.7 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.7 | 1.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.7 | 1.4 | GO:0048627 | myoblast development(GO:0048627) |
| 0.7 | 4.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.7 | 4.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.7 | 4.0 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.6 | 1.9 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.6 | 0.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.6 | 1.3 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.6 | 6.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.6 | 0.6 | GO:0007600 | sensory perception(GO:0007600) |
| 0.6 | 1.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.6 | 1.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.6 | 4.8 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.6 | 3.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.6 | 4.8 | GO:0015908 | fatty acid transport(GO:0015908) long-chain fatty acid transport(GO:0015909) |
| 0.6 | 1.8 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.6 | 3.5 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.6 | 2.9 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.6 | 5.7 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.6 | 3.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.6 | 0.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.6 | 1.7 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 0.5 | 2.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.5 | 1.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.5 | 1.1 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.5 | 0.5 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.5 | 2.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.5 | 3.2 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.5 | 4.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.5 | 1.5 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.5 | 23.1 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 7.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.5 | 1.5 | GO:0050955 | thermoception(GO:0050955) |
| 0.5 | 1.5 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.5 | 1.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.5 | 2.0 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.5 | 3.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.5 | 1.5 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.5 | 1.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.5 | 0.5 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.5 | 7.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.5 | 1.9 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.5 | 3.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.5 | 0.9 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
| 0.5 | 1.9 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.5 | 4.2 | GO:0015840 | urea transport(GO:0015840) |
| 0.5 | 3.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.5 | 10.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.5 | 1.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.5 | 0.9 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.5 | 2.3 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.5 | 1.8 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 | 1.3 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.4 | 1.3 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.4 | 1.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.4 | 3.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.4 | 2.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 | 5.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.4 | 0.4 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.4 | 4.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.4 | 11.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.4 | 1.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.4 | 5.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.4 | 6.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.4 | 9.4 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.4 | 9.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.4 | 1.2 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.4 | 2.0 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.4 | 0.8 | GO:0060022 | hard palate development(GO:0060022) |
| 0.4 | 1.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 0.4 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.4 | 1.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.4 | 0.8 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.4 | 8.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.4 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.4 | 2.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.4 | 0.8 | GO:0051884 | regulation of anagen(GO:0051884) |
| 0.4 | 0.4 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.4 | 7.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.4 | 5.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.4 | 1.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 3.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.4 | 3.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.4 | 1.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.4 | 1.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 | 3.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.4 | 0.7 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.4 | 5.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 | 2.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.4 | 1.1 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
| 0.4 | 1.1 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.4 | 1.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.4 | 2.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 0.4 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.4 | 3.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 3.1 | GO:0046618 | drug export(GO:0046618) |
| 0.3 | 0.3 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.3 | 2.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 | 1.0 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.3 | 1.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.3 | 1.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 | 1.0 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 1.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.3 | 1.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.3 | 1.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.3 | 1.0 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.3 | 1.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 0.3 | 2.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 1.0 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.3 | 6.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 0.7 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.3 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.3 | 4.6 | GO:0060538 | skeletal muscle tissue development(GO:0007519) skeletal muscle organ development(GO:0060538) |
| 0.3 | 1.3 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.3 | 4.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.3 | 3.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.3 | 4.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 2.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 3.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.3 | 0.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.3 | 1.3 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.3 | 0.6 | GO:0007259 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
| 0.3 | 1.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.3 | 2.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 | 0.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.3 | 1.3 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.3 | 1.5 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 | 4.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 | 4.6 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.3 | 9.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.3 | 0.9 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 1.5 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.3 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.3 | 0.9 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.3 | 1.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.3 | 2.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.3 | 2.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.3 | 0.9 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.3 | 1.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 | 2.9 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.3 | 1.7 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 | 1.5 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.3 | 6.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.3 | 0.6 | GO:0015853 | adenine transport(GO:0015853) |
| 0.3 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.3 | 3.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.3 | 1.1 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 | 1.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.3 | 1.7 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.3 | 0.8 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.3 | 5.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 | 1.9 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 | 3.3 | GO:0046959 | habituation(GO:0046959) |
| 0.3 | 6.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 1.3 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.3 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.3 | 1.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.3 | 0.8 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.3 | 0.3 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.3 | 2.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 | 8.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 | 4.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.3 | 14.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.3 | 0.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.2 | 0.7 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 1.7 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 1.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.2 | 1.2 | GO:0030730 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
| 0.2 | 0.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.2 | 2.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 | 1.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.2 | 1.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.2 | 2.2 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 | 1.0 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 1.0 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 | 0.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 1.0 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
| 0.2 | 4.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 | 5.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 2.4 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 1.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 3.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 0.5 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.2 | 6.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 21.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.2 | 1.6 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.2 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 0.5 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.2 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.2 | 0.7 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.2 | 2.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 | 0.7 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.2 | 0.7 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.2 | 2.2 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 | 2.8 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.2 | 2.4 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.2 | 0.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.2 | 1.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.2 | 1.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.2 | 3.5 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.2 | 3.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
| 0.2 | 2.2 | GO:0015747 | urate transport(GO:0015747) |
| 0.2 | 10.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 2.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.2 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 1.1 | GO:0032898 | neurotrophin production(GO:0032898) |
| 0.2 | 1.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 | 0.4 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.2 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.2 | 0.8 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.2 | 0.4 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.2 | 0.4 | GO:1904589 | regulation of protein import(GO:1904589) |
| 0.2 | 11.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.2 | 1.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 | 4.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 1.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 | 7.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.2 | 1.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 | 1.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.2 | 1.0 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.2 | 0.8 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.2 | 1.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 | 0.6 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.2 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 | 0.8 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.2 | 0.6 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.2 | 2.9 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 0.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.2 | 1.3 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.2 | 7.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.2 | 1.3 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 0.8 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 | 0.4 | GO:0060393 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) pathway-restricted SMAD protein phosphorylation(GO:0060389) regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 0.2 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 3.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.2 | 0.6 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.2 | 0.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.2 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.2 | 2.6 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 | 1.6 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.2 | 1.5 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 2.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.2 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.2 | 1.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.2 | 0.5 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.2 | 0.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.2 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 | 0.9 | GO:1904383 | response to sodium phosphate(GO:1904383) response to insulin-like growth factor stimulus(GO:1990418) |
| 0.2 | 3.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 1.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 1.0 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 | 0.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.2 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.2 | 3.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 | 0.2 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.2 | 3.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 0.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.2 | 2.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 2.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 | 0.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.2 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.2 | 2.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 6.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 0.8 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 1.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 | 0.5 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.2 | 0.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.2 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 0.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.2 | 0.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.2 | 0.8 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.2 | 1.0 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.2 | 2.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 1.3 | GO:0015755 | fructose transport(GO:0015755) |
| 0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 | 2.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.2 | 1.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.2 | 0.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 | 1.9 | GO:0000050 | urea cycle(GO:0000050) |
| 0.2 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 0.3 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
| 0.2 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.5 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.2 | 2.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.2 | 0.9 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.2 | 0.6 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
| 0.2 | 1.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.2 | 4.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 | 0.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.2 | 0.6 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.2 | 1.5 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 0.3 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.2 | 0.9 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 | 1.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.2 | 0.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.2 | 2.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 1.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.4 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
| 0.1 | 3.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 1.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.1 | 0.7 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.1 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 3.8 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 1.3 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.1 | 0.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.6 | GO:0070627 | ferrous iron import(GO:0070627) |
| 0.1 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 1.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.1 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.1 | 0.7 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 1.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 | 1.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.1 | 1.0 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 | 1.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 1.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.4 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 | 0.1 | GO:0060281 | regulation of oocyte development(GO:0060281) regulation of oocyte maturation(GO:1900193) |
| 0.1 | 4.5 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 0.4 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 | 0.4 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 0.8 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 0.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 | 3.0 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 2.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 3.2 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 1.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.1 | 0.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.1 | 0.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 | 0.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 9.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.1 | 0.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.1 | 2.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.1 | GO:1902224 | ketone body metabolic process(GO:1902224) |
| 0.1 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 1.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 1.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.4 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 | 11.4 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 1.3 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.1 | 0.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 2.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 2.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 0.9 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 3.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.6 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.1 | 0.8 | GO:0070189 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 | 0.8 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 | 1.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.5 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
| 0.1 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.1 | 0.8 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.1 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.1 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 | 2.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.1 | 5.8 | GO:0042026 | protein refolding(GO:0042026) |
| 0.1 | 0.1 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.1 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 | 2.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 | 0.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.1 | 0.4 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 | 1.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.2 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.1 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.1 | 1.9 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 1.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.1 | 0.5 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
| 0.1 | 0.5 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 0.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.1 | 3.5 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.7 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.1 | 0.7 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 0.2 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.1 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 1.0 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 | 4.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 0.9 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.2 | GO:0051216 | cartilage development(GO:0051216) |
| 0.1 | 0.4 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.1 | 0.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 1.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.2 | GO:0060996 | dendritic spine development(GO:0060996) |
| 0.1 | 0.4 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 1.7 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.1 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 4.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 | 4.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.1 | 2.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 | 1.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 0.2 | GO:0046034 | ATP metabolic process(GO:0046034) |
| 0.1 | 0.6 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 | 3.8 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.6 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 1.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.1 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.1 | 2.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
| 0.1 | 1.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 | 0.4 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.1 | 0.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) selenocysteine biosynthetic process(GO:0016260) |
| 0.1 | 1.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
| 0.1 | 1.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.1 | 2.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.1 | 0.7 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 2.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.4 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
| 0.1 | 0.5 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.1 | 1.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 | 0.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.1 | 0.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 1.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 0.2 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 | 0.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
| 0.1 | 0.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 1.1 | GO:0009415 | response to water(GO:0009415) |
| 0.1 | 0.8 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.3 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 1.1 | GO:0043090 | amino acid import(GO:0043090) |
| 0.1 | 0.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.1 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.2 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 0.9 | GO:0043542 | endothelial cell migration(GO:0043542) |
| 0.1 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.1 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 1.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 3.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.3 | GO:0038086 | coronary vein morphogenesis(GO:0003169) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) cardiac vascular smooth muscle cell development(GO:0060948) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.1 | 0.3 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.1 | 0.3 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 | 0.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.1 | 0.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.1 | 4.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.3 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 | 0.2 | GO:0070781 | response to biotin(GO:0070781) |
| 0.1 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.1 | 2.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 1.6 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 1.8 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 1.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 | 1.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 6.4 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
| 0.1 | 1.8 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.1 | 0.3 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 4.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.1 | 1.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.7 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 0.4 | GO:0033668 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 2.0 | GO:1902001 | carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) |
| 0.1 | 1.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.2 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 | 0.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 0.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.1 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 2.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 | 0.7 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
| 0.1 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 1.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.1 | 0.5 | GO:1901660 | calcium ion export(GO:1901660) |
| 0.1 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 1.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 0.4 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 4.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 4.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.1 | 8.9 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.1 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.1 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.7 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 | 5.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 1.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 | 2.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.1 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.4 | GO:0051828 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.2 | GO:0035194 | posttranscriptional gene silencing by RNA(GO:0035194) |
| 0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 1.1 | GO:0010226 | response to lithium ion(GO:0010226) |
| 0.1 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.3 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.1 | 4.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.1 | 1.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.8 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
| 0.1 | 0.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 2.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 1.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 1.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
| 0.1 | 4.3 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.1 | 0.9 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 0.2 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 | 0.3 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 | 0.3 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.1 | 0.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 | 0.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 0.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 2.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 13.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 1.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 | 0.3 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.1 | 4.0 | GO:0006094 | gluconeogenesis(GO:0006094) |
| 0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
| 0.1 | 0.3 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.1 | 0.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 | 1.5 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.4 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
| 0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 1.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 | 0.3 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 | 0.6 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.1 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.1 | 0.2 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.1 | 0.1 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.1 | 6.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 1.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 3.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 3.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.5 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.1 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 0.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.1 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 0.8 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 | 1.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
| 0.1 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.1 | 1.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.1 | 0.4 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.1 | 0.2 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 | 1.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 0.8 | GO:0006606 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) |
| 0.1 | 0.2 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.5 | GO:0060491 | regulation of cell projection assembly(GO:0060491) |
| 0.1 | 0.4 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 0.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 2.0 | GO:0070741 | response to interleukin-6(GO:0070741) |
| 0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.1 | 1.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.7 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
| 0.1 | 1.4 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 0.8 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) protein depalmitoleylation(GO:1990697) |
| 0.1 | 0.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.0 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.0 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.0 | 0.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 | 2.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 | 0.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.1 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
| 0.0 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 1.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.0 | 0.1 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.0 | 2.4 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.0 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.0 | 0.2 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.0 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.0 | 0.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.0 | 0.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 1.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 0.8 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
| 0.0 | 1.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 | 0.2 | GO:0032400 | melanosome localization(GO:0032400) melanosome transport(GO:0032402) |
| 0.0 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
| 0.0 | 0.2 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
| 0.0 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.3 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 | 0.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 | 0.1 | GO:0051170 | nuclear import(GO:0051170) |
| 0.0 | 0.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.0 | 0.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.2 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.0 | 0.1 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.0 | 1.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
| 0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
| 0.0 | 0.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 | 0.3 | GO:0022011 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.0 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.0 | 0.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.6 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 | 0.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 0.5 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.0 | 1.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 | 0.5 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.0 | 0.6 | GO:0090195 | chemokine secretion(GO:0090195) |
| 0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 | 0.3 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 | 0.0 | GO:0032616 | interleukin-13 production(GO:0032616) |
| 0.0 | 1.0 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.0 | 0.5 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 | 0.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.0 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.0 | 0.8 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.0 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 5.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.7 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 1.3 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.0 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.0 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 | 0.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 | 0.1 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 | 0.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 3.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.0 | 2.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.0 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 | 0.1 | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) |
| 0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.2 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.0 | 0.5 | GO:0072350 | tricarboxylic acid cycle(GO:0006099) tricarboxylic acid metabolic process(GO:0072350) |
| 0.0 | 0.1 | GO:0018199 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
| 0.0 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 | 0.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 | 0.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.0 | 0.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.0 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.2 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.0 | 0.2 | GO:1990834 | response to odorant(GO:1990834) |
| 0.0 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.0 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
| 0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.0 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.0 | 0.4 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.0 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.0 | 0.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 | 0.4 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.0 | 0.0 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.0 | 0.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.0 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.0 | 0.1 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.0 | 0.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.0 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.0 | 0.1 | GO:0045444 | fat cell differentiation(GO:0045444) |
| 0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 | 0.2 | GO:0006833 | water transport(GO:0006833) |
| 0.0 | 0.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 0.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.0 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
| 0.0 | 0.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 | 0.1 | GO:0050890 | cognition(GO:0050890) |
| 0.0 | 0.4 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 | 0.8 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 | 0.1 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 | 0.0 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
| 0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.0 | 0.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.0 | 0.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
| 0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 | 0.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 | 0.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.0 | 0.9 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 | 0.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.0 | 0.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.0 | 0.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 | 0.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.1 | GO:0046056 | dADP biosynthetic process(GO:0006173) purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) dADP metabolic process(GO:0046056) |
| 0.0 | 0.1 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 0.1 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.0 | 0.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.1 | GO:0070894 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 0.0 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
| 0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.0 | GO:2000620 | innate vocalization behavior(GO:0098582) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.0 | 0.0 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 0.2 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.0 | 0.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.0 | 0.2 | GO:0046942 | carboxylic acid transport(GO:0046942) |
| 0.0 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.0 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 | 6.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.2 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.0 | 0.0 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
| 0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 3.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.0 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.0 | 0.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 0.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.0 | GO:1901615 | organic hydroxy compound metabolic process(GO:1901615) |
| 0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.2 | GO:0007098 | centrosome cycle(GO:0007098) |
| 0.0 | 0.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.0 | 0.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 | 0.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.0 | 0.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.0 | 0.2 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.0 | 0.2 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
| 0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.0 | 0.2 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
| 0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.0 | 0.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.0 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 12.5 | GO:0070695 | FHF complex(GO:0070695) |
| 1.3 | 3.9 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 1.2 | 7.2 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 1.1 | 3.4 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 1.0 | 12.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.9 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.9 | 2.6 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.9 | 2.6 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.8 | 14.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.8 | 33.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.8 | 4.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.7 | 6.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.7 | 4.1 | GO:1990357 | terminal web(GO:1990357) |
| 0.7 | 2.0 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 0.6 | 1.7 | GO:0001534 | radial spoke(GO:0001534) |
| 0.5 | 4.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.5 | 4.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.5 | 9.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.5 | 2.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.5 | 4.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.5 | 2.9 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.5 | 4.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.5 | 8.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.5 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
| 0.4 | 6.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 5.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.4 | 0.8 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.4 | 1.6 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.4 | 4.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.4 | 10.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 10.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.4 | 5.1 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.4 | 9.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 16.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.3 | 4.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.3 | 12.0 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.3 | 0.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.3 | 5.8 | GO:0005861 | troponin complex(GO:0005861) |
| 0.3 | 0.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.3 | 7.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.3 | 3.1 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.3 | 0.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.3 | 8.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.3 | 1.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.3 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
| 0.3 | 1.7 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.3 | 0.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.3 | 5.9 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.3 | 3.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.3 | 3.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 9.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 10.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 21.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 3.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.2 | 105.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.2 | 4.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 1.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 1.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.2 | 2.1 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 0.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 2.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.2 | 1.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 5.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.2 | 0.7 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.2 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
| 0.2 | 4.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 16.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 1.0 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.2 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 2.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 4.6 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 10.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 0.6 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.2 | 1.9 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.2 | 6.6 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 8.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 2.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 1.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.1 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 5.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.8 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.1 | 6.3 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.5 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 1.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 0.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.1 | 1.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 5.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.3 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.1 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 32.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 3.8 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 6.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 0.1 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
| 0.1 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 7.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.2 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.1 | 0.1 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.6 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 6.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.1 | 1.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 1.7 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 2.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 1.3 | GO:0036019 | endolysosome(GO:0036019) |
| 0.1 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 3.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 4.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.3 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 0.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 53.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 4.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 6.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 0.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.1 | 0.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.1 | 2.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 17.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 1.1 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 8.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.2 | GO:0075341 | host cell PML body(GO:0075341) |
| 0.1 | 0.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.5 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.2 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.1 | 0.7 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 2.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.2 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.1 | 1.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 2.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 5.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.0 | 0.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 1.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 7.7 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 1.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.0 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.0 | 4.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 13.0 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 0.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.0 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 2.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 14.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 6.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.0 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.0 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.0 | 0.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 1.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.6 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 1.5 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 16.8 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 4.0 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.1 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.0 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.0 | 2.3 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 3.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 0.7 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
| 0.0 | 1.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 3.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 1.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.2 | GO:0031982 | vesicle(GO:0031982) |
| 0.0 | 1.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 8.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 2.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.0 | 2.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.1 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.0 | 1.9 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 21.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 26.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 22.2 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
| 0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.0 | 0.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 0.1 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.1 | GO:0097196 | Shu complex(GO:0097196) |
| 0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.0 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.0 | 0.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.0 | 0.5 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.0 | 1.1 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.5 | GO:0030017 | sarcomere(GO:0030017) |
| 0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.0 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.4 | 21.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 2.7 | 10.7 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 2.3 | 6.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 2.1 | 6.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 1.8 | 7.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.4 | 5.6 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 1.3 | 6.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 1.3 | 2.6 | GO:0005506 | iron ion binding(GO:0005506) |
| 1.2 | 3.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.2 | 9.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 1.2 | 7.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 1.1 | 4.5 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.1 | 3.4 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 1.1 | 3.3 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 1.1 | 5.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.0 | 3.1 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 1.0 | 3.0 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 1.0 | 6.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.9 | 7.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.9 | 1.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.9 | 2.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.9 | 5.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.9 | 16.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.9 | 3.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.9 | 6.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.9 | 15.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.8 | 2.5 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.8 | 3.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.8 | 5.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.8 | 6.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.8 | 3.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.8 | 15.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.8 | 7.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.8 | 15.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.8 | 11.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.8 | 3.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.8 | 3.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.8 | 2.3 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.8 | 9.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.8 | 1.5 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.7 | 2.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.7 | 2.1 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.7 | 2.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.7 | 3.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.6 | 2.6 | GO:0019862 | IgA binding(GO:0019862) |
| 0.6 | 2.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.6 | 1.9 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.6 | 2.4 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.6 | 3.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.6 | 1.8 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.6 | 4.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.6 | 1.8 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.6 | 5.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.6 | 4.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.6 | 6.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.6 | 2.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.5 | 1.6 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.5 | 5.3 | GO:0005497 | androgen binding(GO:0005497) |
| 0.5 | 12.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.5 | 4.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 13.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.5 | 5.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.5 | 8.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.5 | 3.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.5 | 1.6 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.5 | 1.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.5 | 2.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.5 | 1.5 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.5 | 3.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.5 | 2.0 | GO:0004040 | amidase activity(GO:0004040) |
| 0.5 | 6.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.5 | 7.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.5 | 1.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.5 | 7.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.5 | 1.4 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.5 | 1.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.5 | 3.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.5 | 1.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.5 | 1.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 1.3 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.4 | 3.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.4 | 8.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.4 | 1.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.4 | 2.6 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.4 | 2.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.4 | 3.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.4 | 1.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.4 | 3.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.4 | 6.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 7.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 8.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 1.6 | GO:0070404 | NADH binding(GO:0070404) |
| 0.4 | 20.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.4 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.4 | 0.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.4 | 1.2 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.4 | 1.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.4 | 2.0 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.4 | 1.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.4 | 1.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 8.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.4 | 1.5 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.4 | 1.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.4 | 2.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.4 | 2.9 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.4 | 0.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.4 | 3.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 2.9 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 1.8 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.3 | 4.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.3 | 2.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.3 | 3.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.3 | 7.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.3 | 1.0 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.3 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.3 | 1.3 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 0.3 | 8.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.3 | 2.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.3 | 1.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.3 | 10.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.3 | 2.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.3 | 1.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.3 | 6.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.3 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.3 | 1.2 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.3 | 1.4 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.3 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 1.7 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.3 | 1.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.3 | 1.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.3 | 11.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.3 | 2.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.3 | 1.3 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.3 | 4.8 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.3 | 0.8 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.3 | 1.0 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.3 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.3 | 1.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 0.8 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.3 | 1.0 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.3 | 3.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.3 | 1.0 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.3 | 0.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.2 | 1.2 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 1.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.2 | 2.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 1.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.2 | 1.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.2 | 10.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 1.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.2 | 4.4 | GO:0019864 | IgG binding(GO:0019864) |
| 0.2 | 10.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.2 | 2.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.2 | 1.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.2 | 1.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 2.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.2 | 0.9 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.2 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.2 | 6.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 2.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 3.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.2 | 7.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 0.6 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.2 | 0.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.2 | 0.6 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.2 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.2 | 0.8 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.2 | 2.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.2 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.6 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.2 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 7.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.2 | 0.6 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.2 | 3.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 0.6 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.2 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 2.4 | GO:0016594 | glycine binding(GO:0016594) |
| 0.2 | 1.6 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 1.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 1.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.2 | 1.0 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 0.6 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.2 | 1.0 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.2 | 0.2 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.2 | 0.9 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.2 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 0.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.2 | 0.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.2 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 1.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.2 | 4.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 2.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 28.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 1.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 0.5 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.2 | 0.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.2 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 6.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 1.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.2 | 0.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.2 | 0.3 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.2 | 0.8 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 1.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 1.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.2 | 4.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 12.1 | GO:0042805 | actinin binding(GO:0042805) |
| 0.2 | 2.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 0.5 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.2 | 3.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 1.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 1.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 1.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.2 | 4.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.2 | 0.6 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 3.3 | GO:0016769 | transaminase activity(GO:0008483) transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.2 | 1.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.2 | 1.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.2 | 3.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.2 | 3.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 1.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.2 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
| 0.2 | 0.5 | GO:0000035 | acyl binding(GO:0000035) |
| 0.2 | 0.5 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.2 | 0.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.1 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 2.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 7.4 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 3.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 1.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 7.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.0 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 3.1 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 0.6 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.1 | 1.0 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.1 | 3.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.1 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 3.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.1 | 0.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.1 | 1.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 1.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.1 | 0.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.1 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.5 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.1 | 1.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 2.1 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 19.1 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.1 | 11.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 1.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 2.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.5 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.1 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.1 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.1 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.4 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.1 | 5.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.4 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.1 | 4.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 1.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.1 | 1.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 1.1 | GO:0048037 | cofactor binding(GO:0048037) |
| 0.1 | 0.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 2.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 0.3 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.9 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 1.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 2.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.1 | 3.9 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.1 | 0.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 0.3 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 4.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.3 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.1 | 1.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 4.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 3.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.1 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.1 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.3 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 1.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 0.3 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.1 | 1.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.1 | 0.3 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.1 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 1.0 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.1 | 2.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 4.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.1 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.1 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.1 | 0.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
| 0.1 | 0.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 4.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
| 0.1 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
| 0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.1 | 0.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 2.3 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 1.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 1.0 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 0.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 1.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 1.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 1.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 2.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 2.1 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 0.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.1 | 8.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 2.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 1.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.3 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.1 | 4.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 2.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.1 | 10.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 12.1 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.1 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.1 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.1 | 0.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 0.2 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.1 | 1.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.9 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 2.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.1 | 0.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.1 | 3.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 1.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 1.9 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 1.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.1 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.1 | 1.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.1 | 3.4 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.1 | 0.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.1 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 3.3 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.1 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 0.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.2 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.1 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 1.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 2.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 8.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 2.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 0.2 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 10.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 7.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
| 0.1 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.5 | GO:0016874 | ligase activity(GO:0016874) |
| 0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 0.2 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
| 0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 1.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.1 | 0.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.0 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.0 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.0 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.0 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.0 | 0.1 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.0 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.0 | 0.2 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.0 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 1.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.0 | 0.1 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.1 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
| 0.0 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
| 0.0 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.0 | 4.4 | GO:0000166 | nucleotide binding(GO:0000166) nucleoside phosphate binding(GO:1901265) |
| 0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.2 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.0 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 1.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.0 | 2.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 5.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.0 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
| 0.0 | 0.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.0 | 0.1 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.0 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.0 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 1.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.1 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.0 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.0 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 1.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 1.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.0 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.0 | 0.3 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.0 | 29.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.0 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 1.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.0 | 4.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
| 0.0 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.0 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.0 | 0.2 | GO:0001129 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.0 | 1.7 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.0 | 0.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.0 | 0.2 | GO:0008047 | enzyme activator activity(GO:0008047) |
| 0.0 | 0.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.0 | 3.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.0 | 1.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.0 | 0.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.0 | 0.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.0 | 0.2 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
| 0.0 | 0.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.0 | 3.2 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.0 | 1.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 1.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
| 0.0 | 0.0 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.0 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 0.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
| 0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.0 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.0 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 1.0 | GO:0005253 | anion channel activity(GO:0005253) |
| 0.0 | 1.6 | GO:0008144 | drug binding(GO:0008144) |
| 0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 0.0 | 0.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.0 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.0 | 0.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.0 | 0.2 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 1.7 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.0 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.0 | 0.0 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.0 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 3.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.0 | 0.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.0 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.0 | 0.0 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.0 | 0.3 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.0 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 3.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.3 | 15.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 5.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 20.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 21.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.2 | 8.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 3.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 12.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 2.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 5.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 4.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 8.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 6.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 2.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 7.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 3.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 6.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 2.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 2.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 4.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 3.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 6.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 4.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 3.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 46.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.7 | 10.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.6 | 18.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.4 | 8.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.4 | 12.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.4 | 12.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.4 | 10.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 9.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.4 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.3 | 15.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.3 | 10.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.3 | 19.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.3 | 9.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.3 | 8.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 5.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 12.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.2 | 7.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 18.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 10.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 7.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 10.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 22.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 7.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 54.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 7.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 13.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.2 | 7.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 2.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.2 | 4.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 9.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.2 | 9.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 33.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 2.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 6.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 5.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 5.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 2.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 3.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 3.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 3.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 2.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 8.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 4.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 2.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 4.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 4.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 2.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 4.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 4.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 3.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 1.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 2.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 4.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.1 | 5.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 4.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 5.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 3.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 5.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 1.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 1.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 1.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 1.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 5.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 5.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 1.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 2.7 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 5.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 5.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 0.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 3.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 1.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 1.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 1.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 2.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 2.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 2.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.0 | 1.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 0.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 1.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.2 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 1.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 1.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |